Antonina Rait

3.2k total citations
39 papers, 2.5k citations indexed

About

Antonina Rait is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, Antonina Rait has authored 39 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Biotechnology. Recurrent topics in Antonina Rait's work include RNA Interference and Gene Delivery (19 papers), Advanced biosensing and bioanalysis techniques (11 papers) and Cancer Research and Treatments (7 papers). Antonina Rait is often cited by papers focused on RNA Interference and Gene Delivery (19 papers), Advanced biosensing and bioanalysis techniques (11 papers) and Cancer Research and Treatments (7 papers). Antonina Rait collaborates with scholars based in United States, Netherlands and Japan. Antonina Rait's co-authors include Esther H. Chang, Kathleen F. Pirollo, Sang Soo Kim, Wenhua Tang, Liang Xu, Laiman Xiang, Eric H. Kim, Qi Zhou, John A. Dagata and Richard I. Hogrefe and has published in prestigious journals such as Nucleic Acids Research, ACS Nano and Cancer Research.

In The Last Decade

Antonina Rait

39 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonina Rait United States 28 1.6k 699 549 520 401 39 2.5k
Valentina Fogal United States 19 1.8k 1.1× 379 0.5× 758 1.4× 377 0.7× 498 1.2× 21 2.5k
Emilia S. Olson United States 14 1.3k 0.8× 485 0.7× 308 0.6× 853 1.6× 305 0.8× 20 2.4k
Kathleen F. Pirollo United States 38 3.0k 1.8× 1.0k 1.5× 1.7k 3.1× 759 1.5× 840 2.1× 65 4.7k
Chiara Brignole Italy 29 1.4k 0.9× 511 0.7× 494 0.9× 397 0.8× 423 1.1× 55 2.7k
Hiroaki Kinoh Japan 30 1.2k 0.7× 633 0.9× 779 1.4× 666 1.3× 933 2.3× 57 2.8k
Todd A. Aguilera United States 20 1.4k 0.9× 331 0.5× 809 1.5× 835 1.6× 358 0.9× 72 3.3k
Katherine S. Yang United States 24 1.5k 0.9× 407 0.6× 786 1.4× 783 1.5× 450 1.1× 48 2.9k
Maaike Everts United States 24 965 0.6× 239 0.3× 443 0.8× 444 0.9× 111 0.3× 48 1.9k
Daisy W.J. van der Schaft Netherlands 31 1.6k 1.0× 552 0.8× 612 1.1× 695 1.3× 448 1.1× 42 2.8k

Countries citing papers authored by Antonina Rait

Since Specialization
Citations

This map shows the geographic impact of Antonina Rait's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonina Rait with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonina Rait more than expected).

Fields of papers citing papers by Antonina Rait

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonina Rait. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonina Rait. The network helps show where Antonina Rait may publish in the future.

Co-authorship network of co-authors of Antonina Rait

This figure shows the co-authorship network connecting the top 25 collaborators of Antonina Rait. A scholar is included among the top collaborators of Antonina Rait based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonina Rait. Antonina Rait is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Sang Soo, et al.. (2024). SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors. International Journal of Nanomedicine. Volume 19. 5973–5993. 2 indexed citations
2.
Kim, Sang Soo, et al.. (2017). Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide. Nucleic Acids Research. 46(3). 1424–1440. 104 indexed citations
4.
Kim, Sang Soo, Antonina Rait, Abhi K. Rao, et al.. (2013). The Clinical Potential of Targeted Nanomedicine: Delivering to Cancer Stem-like Cells. Molecular Therapy. 22(2). 278–291. 43 indexed citations
5.
Camp, E. Ramsay, Elizabeth C. Little, Paul Watson, et al.. (2013). Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy. Cancer Gene Therapy. 20(4). 222–228. 88 indexed citations
6.
Senzer, Neil, John Nemunaitis, Cynthia Bedell, et al.. (2013). Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors. Molecular Therapy. 21(5). 1096–1103. 186 indexed citations
7.
Yang, Chengli, Antonina Rait, Kathleen F. Pirollo, et al.. (2008). Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo. Nanomedicine Nanotechnology Biology and Medicine. 4(4). 318–329. 50 indexed citations
8.
Hogrefe, Richard I., Alexandre Lebedev, Gerald Zon, et al.. (2006). Chemically Modified Short Interfering Hybrids (siHYBRIDS): Nanoimmunoliposome DeliveryIn VitroandIn Vivofor RNAi of HER-2. Nucleosides Nucleotides & Nucleic Acids. 25(8). 889–907. 45 indexed citations
9.
Pirollo, Kathleen F., Gerald Zon, Antonina Rait, et al.. (2006). Tumor-Targeting Nanoimmunoliposome Complex for Short Interfering RNA Delivery. Human Gene Therapy. 17(1). 117–124. 117 indexed citations
10.
Pirollo, Kathleen F., Gerald Zon, Antonina Rait, et al.. (2005). Tumor-Targeting Nanoimmunoliposome Complex for Short Interfering RNA Delivery. Human Gene Therapy. 0(0). 2462056089–2462056089. 6 indexed citations
11.
Yu, Wei, et al.. (2004). A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene. Gene Therapy. 11(19). 1434–1440. 63 indexed citations
12.
Rait, Antonina, et al.. (2003). HER‐2‐Targeted Antisense Oligonucleotide Results in Sensitization of Head and Neck Cancer Cells to Chemotherapeutic Agents. Annals of the New York Academy of Sciences. 1002(1). 78–89. 26 indexed citations
13.
Pirollo, Kathleen F., Antonina Rait, Leanne S. Sleer, & Esther H. Chang. (2003). Antisense therapeutics: from theory to clinical practice. Pharmacology & Therapeutics. 99(1). 55–77. 80 indexed citations
14.
Rait, Antonina, et al.. (2002). Tumor-targeting, Systemically Delivered Antisense HER-2 Chemosensitizes Human Breast Cancer Xenografts Irrespective of HER-2 Levels. Molecular Medicine. 8(8). 475–486. 46 indexed citations
15.
16.
Rait, Antonina, et al.. (2000). Inhibition of Ras p21 synthesis by antisense undecamers with uniform and specifically arranged phosphorothioate linkages. Anti-Cancer Drugs. 11(3). 181–191. 4 indexed citations
17.
Xu, Liang, Kathleen F. Pirollo, Wenhua Tang, Antonina Rait, & Esther H. Chang. (1999). Transferrin-Liposome-Mediated Systemic p53 Gene Therapy in Combination with Radiation Results in Regression of Human Head and Neck Cancer Xenografts. Human Gene Therapy. 10(18). 2941–2952. 174 indexed citations
18.
Pirollo, Kathleen F., et al.. (1997). Evidence Supporting a Signal Transduction Pathway Leading to the Radiation-Resistant Phenotype in Human Tumor Cells. Biochemical and Biophysical Research Communications. 230(1). 196–201. 61 indexed citations
19.
Pirollo, Kathleen F., Antonina Rait, Willard E. Fee, et al.. (1997). p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy. Oncogene. 14(14). 1735–1746. 103 indexed citations
20.
Chang, Esther H., Young‐Ju Jang, Hao Zhou, et al.. (1997). Restoration of the G1 Checkpoint and the Apoptotic Pathway Mediated by Wild-type p53 Sensitizes Squamous Cell Carcinoma of the Head and Neck to Radiotherapy. Archives of Otolaryngology - Head and Neck Surgery. 123(5). 507–512. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026